Company news
Scancell Holdings Plc (LSE:SCLP) news
Scancell Holdings Plc news releases on 6ix. Latest, Dec 14, 2017: Scancell and CRUK to advance cancer immunotherapy
Press releases — page 5
Scancell and CRUK to advance cancer immunotherapy
December 14, 2017
Presents Moditope Data at Immunotherapy Conference
September 11, 2017
Oncimmune and Scancell Present Autoantibodies Data
August 29, 2017
Continued Progress on SCIB1
July 11, 2017
DNA ImmunoBody Patent Granted in Europe
June 26, 2017
Proposed Placing to Raise up to £5.0 million
May 11, 2017
Immuno-Oncology Summit Europe 2017
March 20, 2017
Hardman Research: SCIB development update
March 13, 2017
Partnership to Advance Lung Cancer Clinical Trials
January 30, 2017
Research Update - Amendment
January 3, 2017
World Immunotherapy Congress and Biotech and Money
November 14, 2016
Preparing SCIB2 for clinical study in lung cancer
October 10, 2016
Hardman Report: New frontiers in T-cell activation
September 26, 2016
Notice of AGM - Amendment
September 23, 2016
NewsMakers in the Biotech Industry Conference
September 7, 2016
Appointment of Non-Executive Director
August 22, 2016
Eurogentec manufacturing agreement
July 21, 2016
Extension to Ichor Commercial Option
July 20, 2016
Peer-reviewed publication on Moditope® platform
July 13, 2016
SCIB1 compelling survival data in melanoma
July 6, 2016
SCIB1 Drug Product Supply
June 17, 2016
Development of ImmunoBody® Vaccine
June 2, 2016
Opens US Headquarters in San Diego
May 18, 2016
Result of the open offer
April 4, 2016
Result of open offer
April 1, 2016
World Cancer Vaccine Congress
March 23, 2016
Strategic collaboration with Karolinska Institutet
March 11, 2016
Placing and Open Offer Close
March 9, 2016
Proposed Placing and Open Offer
March 9, 2016
Presenting at the Biotech Capital Conference
February 23, 2016
Amendment to Options
January 27, 2016
Half Yearly Report
January 27, 2016
SCIB1 Early Immune Effect Observed by ImmunTraCkeR
January 11, 2016
Key Moditope paper published in Cancer Research
January 5, 2016
US Phase II combination study with SCIB1
December 18, 2015
AGM Business Update
October 20, 2015
Six scientific presentations at PIVAC Conference
October 6, 2015
Final Results for the year ended 30 April 2015
September 18, 2015
ImmunoBody presented at Cancer Vaccines Conference
September 16, 2015
Collaboration with ImmunID
July 30, 2015
Patient recruitment completed for SCIB1 trial
July 9, 2015
SCIB1 data update in resected melanoma patients
June 2, 2015
Update on SCIB1 data at 2015 ASCO Annual Meeting
May 18, 2015
Poster on Moditope to be presented at AACR
April 17, 2015
SCIB2 synergy with checkpoint inhibitor blockade
March 24, 2015
Positive SCIB1 Phase 1/2 clinical trial update
January 12, 2015
Appointment of Nominated Adviser and Broker
October 14, 2014
AGM research and development update
October 14, 2014
Present at the 14th Annual Biotech in Europe Forum
September 30, 2014
Presenting at Upcoming Scientific Conferences
September 12, 2014